Barely Significant
← all excerpts

Consecutive epigenetically-active agent combinations act in <i>ID1-RUNX3-TET2</i> and <i>HOXA</i> pathways for <i>Flt3ITD+ve</i> AML.

Oncotarget · 2018 · PMC5814168 · PMID 29464028

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

of borderline significancep=0.07so close (0.05 < p ≤ 0.1)
There was derepression in CDKN2A transcripts of borderline significance (p=0.07), and no change in ID1 expression (Figure 3b ; and data not shown).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.